MAIN ARTICLE
Stable sales, more fragile earnings
The Bad Homburg-based group reported third-quarter revenue of €4.937 billion, up 1% from a year earlier, while organic revenue was essentially flat. Adjusted operating income fell to €545 million from €574 million, and the adjusted margin narrowed to 11.0% from 11.7%. That gap underscores how modest sales growth can coexist with declining profitability when labor costs and reimbursement pressures outpace operational improvements.
The difference between adjusted and reported results was especially pronounced. Reported operating income declined 19% to €384 million, while net income attributable to shareholders fell 42% to €160 million. One-time expenses connected with changes to the company’s China strategy weighed on the accounts. Reuters reported that the steps included discontinuing a dialysis system and withdrawing from peritoneal dialysis activities there.
The revised guidance should not be mistaken for a forecast of an operating loss. It describes the expected annual change in adjusted operating income at constant currency. An earlier range allowing for a modest increase has been narrowed to flat performance or a mid-single-digit decline. Revenue guidance remains broadly unchanged.
















